Hawkins Capital LP Boosted Its Dorchester Minerals LP (DMLP) Position, Profile of 3 Analysts Covering Natus Medical (BABY)

July 6, 2017 - By Nellie Frank

Among 4 analysts covering Natus Medical (NASDAQ:BABY), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Natus Medical had 7 analyst reports since July 23, 2015 according to SRatingsIntel. The company was upgraded on Tuesday, September 13 by Raymond James. The rating was downgraded by Raymond James to “Mkt Perform” on Thursday, February 2. The stock of Natus Medical Inc (NASDAQ:BABY) has “Buy” rating given on Tuesday, January 12 by TH Capital. The firm has “Buy” rating given on Thursday, July 23 by TH Capital. Roth Capital maintained Natus Medical Inc (NASDAQ:BABY) on Tuesday, April 5 with “Buy” rating. On Tuesday, October 4 the stock rating was initiated by Benchmark with “Buy”. TH Capital maintained Natus Medical Inc (NASDAQ:BABY) rating on Thursday, October 22. TH Capital has “Buy” rating and $53 target. See Natus Medical Inc (NASDAQ:BABY) latest ratings:

02/02/2017 Broker: Raymond James Old Rating: Outperform New Rating: Mkt Perform Downgrade

Hawkins Capital Lp increased Dorchester Minerals Lp (DMLP) stake by 9920% reported in 2016Q4 SEC filing. Hawkins Capital Lp acquired 49,600 shares as Dorchester Minerals Lp (DMLP)’s stock declined 1.48%. The Hawkins Capital Lp holds 50,100 shares with $879,000 value, up from 500 last quarter. Dorchester Minerals Lp now has $438.78M valuation. The stock rose 2.42% or $0.35 reaching $14.8 per share. About 15,636 shares traded. Dorchester Minerals LP (NASDAQ:DMLP) has risen 34.09% since July 6, 2016 and is uptrending. It has outperformed by 17.39% the S&P500.

About 37,098 shares traded. Natus Medical Inc (NASDAQ:BABY) has risen 4.38% since July 6, 2016 and is uptrending. It has underperformed by 12.32% the S&P500.

Investors sentiment increased to 1.93 in Q4 2016. Its up 0.82, from 1.11 in 2016Q3. It increased, as 11 investors sold Natus Medical Inc shares while 56 reduced holdings. 51 funds opened positions while 78 raised stakes. 29.10 million shares or 6.34% more from 27.36 million shares in 2016Q3 were reported. Tdam Usa Incorporated holds 0.05% of its portfolio in Natus Medical Inc (NASDAQ:BABY) for 26,890 shares. The New York-based Renaissance Technologies has invested 0% in Natus Medical Inc (NASDAQ:BABY). California-based Clarivest Asset Management Ltd Liability Co has invested 0.03% in Natus Medical Inc (NASDAQ:BABY). Diamond Hill holds 0.12% of its portfolio in Natus Medical Inc (NASDAQ:BABY) for 589,551 shares. State Board Of Administration Of Florida Retirement invested 0% in Natus Medical Inc (NASDAQ:BABY). Mason Street Advsrs Limited Liability Company owns 0.01% invested in Natus Medical Inc (NASDAQ:BABY) for 7,192 shares. Glenmede Tru Communication Na holds 16,777 shares or 0% of its portfolio. 132,632 were reported by Goldman Sachs Gp. Bancorporation Of Montreal Can reported 56,153 shares or 0% of all its holdings. Citadel Advsr Ltd Liability Co owns 218,132 shares. California-based Los Angeles Cap Mngmt And Equity Research Inc has invested 0.01% in Natus Medical Inc (NASDAQ:BABY). Tower Rech Capital Lc (Trc) invested in 851 shares or 0% of the stock. Blackrock Investment Management Ltd Liability Company owns 167,654 shares. Arizona State Retirement Systems has 16,906 shares for 0.01% of their portfolio. Stifel Finance has 209,766 shares.

Since February 9, 2017, it had 2 insider purchases, and 3 sales for $190,940 activity. Shares for $163,400 were sold by Engibous Doris on Thursday, May 25. $135,900 worth of Natus Medical Inc (NASDAQ:BABY) was bought by HAWKINS JAMES B. Another trade for 5,000 shares valued at $180,000 was sold by GUNST ROBERT A. The insider MOORE WILLIAM M sold $186,300.

Natus Medical Incorporated is a provider of newborn care and neurology healthcare services and products used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders. The company has market cap of $1.25 billion. The Company’s product offerings include computerized neurodiagnostic systems for audiology, neurology, polysomnography, and neonatology, as well as newborn care products, such as hearing screening systems, phototherapy devices for the treatment of newborn jaundice, head-cooling products for the treatment of brain injury in newborns, incubators to control the newborn’s environment, and software systems for managing and tracking disorders and diseases for public health laboratories. It has a 34.29 P/E ratio.

Since March 9, 2017, it had 1 insider buy, and 0 insider sales for $29,323 activity. 1,827 Dorchester Minerals LP (NASDAQ:DMLP) shares with value of $29,323 were bought by EHRMAN BRADLEY J.

Hawkins Capital Lp decreased American Intl Group Inc (NYSE:AIG) stake by 55,000 shares to 201,500 valued at $13.16 million in 2016Q4. It also reduced Corning Inc (NYSE:GLW) stake by 37,000 shares and now owns 212,000 shares. General Electric Co (NYSE:GE) was reduced too.

Investors sentiment increased to 0.88 in 2016 Q4. Its up 0.11, from 0.77 in 2016Q3. It improved, as 11 investors sold DMLP shares while 13 reduced holdings. 5 funds opened positions while 16 raised stakes. 3.74 million shares or 5.50% less from 3.95 million shares in 2016Q3 were reported. Adams Asset Advsrs Ltd Limited Liability Company invested in 1.45% or 628,032 shares. Creative Planning holds 0.01% of its portfolio in Dorchester Minerals LP (NASDAQ:DMLP) for 50,860 shares. Deutsche Retail Bank Ag holds 0% or 67,545 shares in its portfolio. Hawkins Cap Ltd Partnership reported 50,100 shares stake. Us Savings Bank De has 0% invested in Dorchester Minerals LP (NASDAQ:DMLP). 156,283 are held by Botty Limited Liability Company. Fiduciary Trust accumulated 11,250 shares. First Manhattan has invested 0% in Dorchester Minerals LP (NASDAQ:DMLP). Comml Bank Of America De owns 133,313 shares. Raymond James Finance Services Advisors stated it has 0% of its portfolio in Dorchester Minerals LP (NASDAQ:DMLP). Penn Davis Mcfarland has invested 0.47% in Dorchester Minerals LP (NASDAQ:DMLP). Moreover, Bessemer Gp has 0% invested in Dorchester Minerals LP (NASDAQ:DMLP) for 5,600 shares. Sanctuary Wealth Advsrs Limited invested in 3.53% or 226,594 shares. Mcdaniel Terry & invested 0.27% of its portfolio in Dorchester Minerals LP (NASDAQ:DMLP). Tower Research Capital Limited Liability Company (Trc) owns 584 shares or 0% of their US portfolio.